Terms: = Uterine cancer AND RUNX1, PEBP2A2, 861, ENSG00000159216, Q01196, AML1, CBFA2, AMLCR1 AND Treatment
33 results:
1. Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study.
Tewari KS; Sill MW; Birrer MJ; Penson RT; Huang H; Moore DH; Ramondetta LM; Landrum LM; Oaknin A; Reid TJ; Leitao MM; Michael HE; Monk BJ
Gynecol Oncol; 2023 Apr; 171():141-150. PubMed ID: 36898292
[TBL] [Abstract] [Full Text] [Related]
2. Long-term incidence of endometrial cancer after endometrial resection and ablation: A population based Swedish gynecologic cancer group (SweGCG) study.
Flöter Rådestad A; Dahm-Kähler P; Holmberg E; Bjurberg M; Hellman K; Högberg T; Kjölhede P; Marcickiewicz J; Rosenberg P; Stålberg K; Åvall-Lundqvist E; Borgfeldt C
Acta Obstet Gynecol Scand; 2022 Aug; 101(8):923-930. PubMed ID: 35624547
[TBL] [Abstract] [Full Text] [Related]
3. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.
Herrera Cappelletti E; Humann J; Torrejón R; Gambadauro P
Hum Reprod Update; 2022 Feb; 28(2):282-295. PubMed ID: 34935045
[TBL] [Abstract] [Full Text] [Related]
4. Deep learning-based auto-segmentation of clinical target volumes for radiotherapy treatment of cervical cancer.
Ma CY; Zhou JY; Xu XT; Guo J; Han MF; Gao YZ; Du H; Stahl JN; Maltz JS
J Appl Clin Med Phys; 2022 Feb; 23(2):e13470. PubMed ID: 34807501
[TBL] [Abstract] [Full Text] [Related]
5. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic cancer Care in an Equal-Access System.
Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
[TBL] [Abstract] [Full Text] [Related]
6. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract] [Full Text] [Related]
7. A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy.
Ou Z; Zhao D; Li B; Wang Y; Liu S; Zhang Y
Cancer Res Treat; 2021 Jan; 53(1):233-242. PubMed ID: 32972047
[TBL] [Abstract] [Full Text] [Related]
8. Effectiveness and Long-term Outcomes of Nerve-Sparing Radical Hysterectomy for Cervical cancer.
Yamamoto A; Kamoi S; Ikeda M; Yamada T; Yoneyama K; Takeshita T
J Nippon Med Sch; 2021 Nov; 88(5):386-397. PubMed ID: 32741908
[TBL] [Abstract] [Full Text] [Related]
9. Insurance Status Predicts Survival in Women with Breast cancer: Results of Breast and Cervical cancer treatment Program in California.
Nelson RA; Bostanci Z; Jones V; Mortimer J; Polverini A; Taylor L; Yee L; Yim JH; Kruper L
Ann Surg Oncol; 2020 Jul; 27(7):2177-2187. PubMed ID: 31965375
[TBL] [Abstract] [Full Text] [Related]
10. Survival and toxicity in neoadjuvant chemotherapy plus surgery versus definitive chemoradiotherapy for cervical cancer: A systematic review and meta-analysis.
Marchetti C; Fagotti A; Tombolini V; Scambia G; De Felice F
Cancer Treat Rev; 2020 Feb; 83():101945. PubMed ID: 31838220
[TBL] [Abstract] [Full Text] [Related]
11. Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation.
Latham AH; Chen L; Hou JY; Tergas AI; Khoury-Collado F; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2019 Oct; 155(1):13-20. PubMed ID: 31395371
[TBL] [Abstract] [Full Text] [Related]
12. cancer treatment and survivorship statistics, 2019.
Miller KD; Nogueira L; Mariotto AB; Rowland JH; Yabroff KR; Alfano CM; Jemal A; Kramer JL; Siegel RL
CA Cancer J Clin; 2019 Sep; 69(5):363-385. PubMed ID: 31184787
[TBL] [Abstract] [Full Text] [Related]
13. Impact of Radical Hysterectomy Versus Simple Hysterectomy on Survival of Patients with Stage 2 Endometrial cancer: A Meta-analysis.
Liu T; Tu H; Li Y; Liu Z; Liu G; Gu H
Ann Surg Oncol; 2019 Sep; 26(9):2933-2942. PubMed ID: 31147990
[TBL] [Abstract] [Full Text] [Related]
14. Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis.
Sud S; Holmes J; Eblan M; Chen R; Jones E
Gynecol Oncol; 2018 Feb; 148(2):349-356. PubMed ID: 29276059
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of Delivery Costs for External Beam Radiation Therapy and Brachytherapy for Locally Advanced Cervical cancer Using Time-Driven Activity-Based Costing.
Bauer-Nilsen K; Hill C; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):88-94. PubMed ID: 29079120
[TBL] [Abstract] [Full Text] [Related]
16. Monitoring Leiomyoma Response to uterine Artery Embolization Using Diffusion and Perfusion Indices from Diffusion-Weighted Imaging.
Cao M; Qian L; Zhang X; Suo X; Lu Q; Zhao H; Liu J; Qu J; Zhou Y; Xu J; Suo S
Biomed Res Int; 2017; 2017():3805073. PubMed ID: 28929111
[TBL] [Abstract] [Full Text] [Related]
17. Social determinants of access to minimally invasive hysterectomy: reevaluating the relationship between race and route of hysterectomy for benign disease.
Price JT; Zimmerman LD; Koelper NC; Sammel MD; Lee S; Butts SF
Am J Obstet Gynecol; 2017 Nov; 217(5):572.e1-572.e10. PubMed ID: 28784416
[TBL] [Abstract] [Full Text] [Related]
18. Predicting poor prognosis recurrence in women with endometrial cancer: a nomogram developed by the FRANCOGYN study group.
Ouldamer L; Bendifallah S; Body G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M
Br J Cancer; 2016 Nov; 115(11):1296-1303. PubMed ID: 27824810
[TBL] [Abstract] [Full Text] [Related]
19. Evaluation of Metachronous Breast and Endometrial cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use.
Grzankowski KS; Szender JB; Spring-Robinson CL; Lele SB; Odunsi KO; Frederick PJ
Int J Gynecol Cancer; 2016 Oct; 26(8):1440-7. PubMed ID: 27648713
[TBL] [Abstract] [Full Text] [Related]
20. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session.
Oh D; Huh SJ; Park W; Ju SG; Nam H; Lee JE
Medicine (Baltimore); 2016 Jun; 95(25):e3895. PubMed ID: 27336876
[TBL] [Abstract] [Full Text] [Related]
[Next]
